Mind'sEye Diagnostics

Company Overview

Snapshot

Founded in January 2017 by Ophir Atar, Mind'sEye Diagnostics operated with 1–10 employees. The company raised $700,000 across one funding round from eHealth Ventures. The company ceased operations in November 2022.

Business overview

Mind'sEye Diagnostics developed a mobile platform designed for the diagnosis and monitoring of ADHD. Its core technology identifies unique eye patterns associated with ADHD, providing an attention score that aids in diagnosis, medication management, and activity recommendations. The system utilizes a phone's camera to scan the user's eye, determining factors affecting attention levels and suggesting interventions like specific foods or physical activities. The company operated within the Health Tech & Life Sciences sector, specifically focusing on Digital Medical Diagnostics and Digital Healthcare, serving patients in markets such as Israel and Europe.

Company Intelligence Q&A

What is Mind'sEye Diagnostics' primary focus?

Mind'sEye Diagnostics focuses on providing a mobile platform for the diagnosis and monitoring of ADHD using eye biomarkers.

When was Mind'sEye Diagnostics founded?

Mind'sEye Diagnostics was founded in January 2017.

What is the status of Mind'sEye Diagnostics?

Mind'sEye Diagnostics is currently non-active, having ceased operations in November 2022.

Who founded Mind'sEye Diagnostics?

Mind'sEye Diagnostics was founded by Ophir Atar.

What technology does Mind'sEye Diagnostics utilize?

Mind'sEye Diagnostics utilizes a mobile app that employs a phone's camera to scan a user's eye, identifying eye patterns unique to ADHD to determine attention levels.